Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12281070 | Water soluble antiviral and antimicrobial compound and process for preparation thereof | Nilanjan Deb | 2025-04-22 |
| 12167360 | Event triggered network migration of subscribers | Ryan P. Dreiling, Philip Warren Uehling, Vijay Bhanu Reddy Yelmat | 2024-12-10 |
| 11864148 | Event triggered network migration of subscribers | Ryan P. Dreiling, Philip Warren Uehling, Vijay Bhanu Reddy Yelmat | 2024-01-02 |
| 11743385 | System and method for calculating agent skill satisfaction index and utilization thereof | Abhijit Wasulkar, Jason Williams, Priyanka Sutar | 2023-08-29 |
| 11616880 | System and method for calculating agent skill satisfaction index and utilization thereof | Abhijit Wasulkar, Jason Williams, Priyanka Sutar | 2023-03-28 |
| 10972910 | Restricting communication using operator determined barring | Hung Bui, Kenneth Lockie, Jonathan Weintraub | 2021-04-06 |
| 10952442 | Automated preparation of breads | Arvind Sharma | 2021-03-23 |
| 10806723 | Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders | David Wald, Mahesh Kumar Gundluru, Goutam Karan, Zhiqiang Xia | 2020-10-20 |
| 10183912 | HDMX inhibitors and their use for cancer treatment | David Wald, Zhiqing Xia, Goutam Karan, Mahesh Kumar Gundluru | 2019-01-22 |
| 10149838 | Small molecule securinine and norsecurinine analogs and their use in inhibiting myeloperoxidase | Mahesh Kumar Gundluru, Zhiqing Xia, Goutam Karan, David Wald | 2018-12-11 |
| 10130616 | Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders | David Wald, Mahesh Kumar Gundluru, Goutam Karan, Zhiqiang Xia | 2018-11-20 |
| 9827229 | Small molecule securinine and norsecurinine analogs and their use in cancers, inflammatory diseases and infections | Mahesh Kumar Gundluru, Zhiqing Xia, Goutam Karan, David Wald | 2017-11-28 |
| 8688072 | Agent notification triggered by network access failure | Sarah Ann Vida Persson | 2014-04-01 |